biomedicina slovenica


"Phospholipid antibodies" : 101-169

  1. Ambrožič Aleš; Kveder Tanja; Rozman Blaž; Matsuura Eiji
    The relationship of OXLDL, beta2GPI and beta2GPI-OXLDL complexes in patients with APS
    2004
  2. Salobir Barbara; Šabovič Mišo
    Interleukin-6 and antiphospholipid antibodies in women with contraceptive-related thromboembolic disease
    2004
  3. Čučnik S; Kveder T; Rozman B; Božič B
    The recognition of beta2GPI by polyclonal anti-beta2GPI antibodies
    2004
  4. Čučnik S; Kveder T; Križaj I; Rozman B; Božič B
    Anti-beta2-glycoprotein I antibodies' avidity
    2004
  5. Božič B; Čučnik S; Kveder T; Rozman B
    Association of high avidity anti-beta2GPI antibodies with thrombosis in patients with APS
    2004
  6. Avčin T; Martinuc J; Kuhar M; Božič B; Čučnik S; Zupančič M; Kveder T; Rozman B
    Antiphospholipid antibodies following vaccination with recombinant hepatitis B vaccine
    2004
  7. Ambrožič Aleš; Božič Borut; Čučnik Saša; Kveder Tanja; Rozman Blaž
    Prothrombin fragment 1+2 as a marker of hypercoagulable state in patients with antiphospholipid antibodies
    [Protrombinski fragment 1+2 kot označevalec hiperkoagulabilnega stanja pri bolnikih z antifosfolipidnimi protitelesi]
    2004
  8. Ambrožič Aleš
    Lastnosti in mehanizmi trombogenega delovanja protiteles proti beta2-glikoproteinu 1
    2004
  9. Avčin T; Markelj G; Nikšič V; Rener-Primec Z; Čučnik S; Zupančič M; Rozman B; Neubauer D
    Estimation of antiphospholipid antibodies in a prospective longitudinal study of children with migraine
    2004
  10. Čučnik Saša
    Pomen avidnosti protiteles proti beta2-glikoproteinu I pri bolnikih s sistemskimi avtoimunskimi boleznimi
    [The importance of anti-beta2-glycoprotein I antibodies' avidity in patients with systemic autoimmune diseases]
    2004
  11. Ambrožič Aleš; Tomšič Matija
    Antiphospholipid antibodies and pregnancy morbidity
    2004
  12. Salobir B; Šabovič M; Hojnik M; Čučnik S; Kveder T
    Antiphospholipid antibodies in young women without autoimmune diseases and suffering from arterial or venous thromboses
    2003
  13. Ambrožič A; Božič B; Rozman B
    Elevated levels of prothrombin fragment 1+2 in patients with antiphospholipid antibodies but without clinical signs of antiphospholipid syndrome
    2003
  14. Markelj Gašper; Nikšič Vesna
    Pomen in vloga antifosfolipidnih protiteles pri mladih z migrenskim glavobolom
    2003
  15. Ambrožič A; Božič B; Čučnik S; Rozman B
    Prothrombin fragment F1+2 in patients with antiphospholipid antibodies
    2004
  16. Avčin Tadej
    Podrobna specifičnost in pomen antifosfolipidnih protiteles v otroškem obdobju
    [The fine specificity and significance of antiphosholipid antibodies in pediatric populations]
    2003
  17. Avčin Tadej; Jazbec Janez; Kuhar Marijana; Zupančič Mirjana; Rozman Blaž
    Evans syndrome associated with antiphospholipid antibodies
    2003
  18. Gašperšič N; Rot U; Čučnik S; Božič B; Kveder T; Rozman B
    Low prevalence of antiphospholipid antibodies in a series of young patients with cerebrovascular disease
    2003
  19. Gašperšič Nataša
    Aneksin V, kofaktor za antifosfolipidna protitelesa in njegova vloga pri bolnikih z ishemično možganskožilno boleznijo
    2003
  20. Čučnik Saša; Božič Borut
    Cerebrovascular manifestations in antiphospholipid syndrome
    2001
  21. Stegnar M; Salobir-Pajnič B; Božič B; Rozman B
    Relationship between lupus anticoagulants and antiphospholipid antibodies detected by enzyme - linked immunosorbent assay
    1992
  22. Ambrožič Aleš; Tomšič Matija
    Ugotavljanje antifosfolipidnega sindroma pri nosečnicah
    [Assessment of antiphospholipid syndrome in women with obstetric complications]
    2003
  23. Mušič P; Šoštarič M
    A case report of patient with antiphospholipid syndrome
    2003
  24. Ambrožič Aleš; Avčin Tadej; Ichikawa Kenji; Kveder Tanja; Matsuura Eiji; Hojnik Maja; Atsumi Tatsuya; Rozman Blaž; Koike Takao
    Anti-beta(2)-glycoprotein I antibodies in children with atopic dermatitis
    2002
  25. Čučnik S; Gašperšič N; Rot U; Božič B; Kveder T
    Cerebrovascular insult and antiphospholipid antibodies in young adults
    2002
  26. Gašperšič N; Čučnik S; Kveder T; Božič B
    Do IgA antiphospholipid antibodies have any clinical importance?
    2002
  27. Ambrožič A; Kveder T; Žigon P; Božič B
    Optimization of phosphatidylserine dependent anti-prothrombin ELISA
    2002
  28. Logar D; Vidan-Jeras B; Ambrožič A; Dolžan V; Hojnik M
    The association of the antiphospholipid antibody response with DRB1/DQB1 coding and QBP promoter polymorphism
    2002
  29. Božič B; Čučnik S; Križaj I; Kveder T
    Protein C inhibitor, isolated together with beta2glycoprotein I, reacted with APS sera
    2002
  30. Gašperšič N; Kveder T; Božič B
    The influence of calcium ions on the detection of anti-annexin V antibodies
    2002
  31. Čučnik S; Kveder T; Božič B
    Heterogeneity of anti-prothrombin antibodies, detected by diferent ELISAs
    2002
  32. Ambrožič A; Svetina S; Majhenc J; Arrigler V; Božič B; Kveder T
    Anti-beta2-glycoprotein I antibodis from patients with APS enhance budding of phospholipid membranes
    2002
  33. Avčin T; Ambrožič A; Božič B; Kuhar M; Kveder T; Rozman B
    Transitory production of anti-beta 2 glycoprotein I antibodies (anti-beta2GPI) in infants with atopic dermatitis: new evidence supporting the role of dietary beta 2 glycoprotein I
    2002
  34. Božič B; Čučnik S; Gašperšič N; Ambrožič A; Rozman B; Kveder T
    Antibodies against prothrombin and annexin V
    2002
  35. Salobir B; Šabovič M; Koželj M
    Increased levels of antiphospholipid antibodies in a woman with left atrial myxoma and systemic embolisms
    2001
  36. Reber Guido; Schousboe Inger; Tincani Angela; Sanmarco Marielle; Kveder Tanja; de Moerloose Philippe; Boffa Marie-Claire; Arvieux Josiane
    Inter-laboratory variability of anti-beta2-glycoprotein I measurement: a collaborative study in the frame of the European forum on antiphospholipid antibodies standardization group
    2002
  37. Rot U; Gašperšič N; Čučnik S; Božič B; Kveder T; Rozman B
    Antiphospholipid antibodies in young adults with neurological disorders
    2002
  38. Avčin T; Cimaz R; Meroni PL
    Recent advances in antiphospholipid antibodies and antiphopsholipid syndromes in pediatric populations
    2002
  39. Ambrožič A; Božič B; Hojnik M; Kveder T; Rozman B
    Antiphospholipid antibodies and rheumatoid arthritis
    2002
  40. Galli M
    Antiphospholipid antibodies: predictive value of laboratory tests
    2001
  41. Avčin Tadej
    Antifosfolipidna protitelesa v serumih zdravih otrok in otrok z juvenilnim idiopatičnim artritisom
    2001
  42. Čučnik Saša; Ambrožič Aleš; Božič Borut; Skitek Milan; Kveder Tanja
    Anti-beta2-glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards
    2000
  43. Božič Borut
    Antifosfolipidna protitelesa pri okužbah
    [Antiphospholipid antibodies and infection]
    2000
  44. von Lindenberg P; Ulcova-Gallova Z; Youinou P; Szegedi G; Meroni PL; Tincani A; Pengo V; Doria A; Praprotnik S; Rozman B
    Autoantibodies to cardiolipin, beta2-glycoprotein I, synthetic peptides and correlation with the clinical manifestations in a European APS population
    2000
  45. Miri Blank; Praprotnik Sonja; Krause Ilian; Schoenfeld Yehuda
    Molecular mimicry between microbial pathogens and beta2GPI - the induction of experimental APS
    2000
  46. Avčin T; Ambrožič A; Kveder T; Kuhar M; Rozman B
    aCL and anti-beta2GPI in sera of 61 apparently healthy children at regular preventive visits
    2000
  47. Ambrožič Aleš; Božič Borut; Avčin Tadej; Kveder Tanja
    The interference effect of BSA used as the blocking agent in an anti-beta2GPI ELISA
    2000
  48. Čučnik Saša; Božič Borut; Ambrožič Aleš; Skitek Milan; Kveder Tanja
    The evaluation of anti-beta2GP 1 ELISA by analytical goals based on biological variations
    2000
  49. Ambrožič Aleš; Kveder Tanja; Ichikawa Kenji; Avčin Tadej; Matsuura Eiji; Rozman Blaž; Koike Takao
    Anti-beta-2-glycoprotein 1 antibodies in children with atopic dermatitis
    2000
  50. Šipek-Dolničar Alenka; Hojnik Maja; Rozman Blaž; Vizjak Alenka; Ferluga Dušan
    Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome
    2000
  51. Ferluga Dušan; Jerše Maja; Vizjak Alenka; Hvala Anastazija; Rozman Blaž; Kos-Golja Mojca; Bren Andrej F
    Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE
    2000
  52. Čučnik Saša
    Antifosfolipidna protitelesa pri trombozi, aterosklerozi in hipertenziji
    2000
  53. Kveder T; Božič B; Stegnar M; Vene N; Peternel P; Rozman B
    Possible influence of anti-phospholipid antibodies on plasminogen activator ihibitor actvity in patients with antiphospholipid syndrome
    1990
  54. Avčin Tadej
    Antifosfolipidna protitelesa v pediatriji
    [Antiphospholipid antibodies in pediatrics]
    1999
  55. Avčin Tadej; Sedmak Marjeta; Anžič Jožica; Accetto Meta
    Antiphospholipid antibodies in a 1.5-year-old girl with a history of probable intrauterine thrombosis
    1999
  56. Praprotnik S; Božič B
    A decrease in antiphospholipid antibodies before a thrombotic event
    1996
  57. Hojnik Maja
    Imunogenost in patogenost različnih oblik beta2-glikoproteina I pri antifosfolipidnem sindromu
    [Immunogenicity and pathogenicity of different forms of beta2- glycoprotein I in the antiphospholipid syndrome]
    1997
  58. Nogay Hasan A; Cimsit Maide
    Hyperbaric oxygen therapy for thrombotic complications in patients with antiphospholipid antibodies
    1997
  59. George Jacob; Blank Miri; Gilburd Boris; Hojnik Maya; Shenkman Boris; Tamarin Ilia; Varon David; Matsuura Eiji; Koike Takao; Shoenfeld Yehuda
    Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta2-glycoprotein I
    1997
  60. Božič B; Kveder T; Stegnar M; Morosini-Berus E; Kos-Golja M; Peternel P; Rozman B
    Influence of degraded phosphatidylserine on binding of antiphospholipid antibodies
    1997
  61. Hojnik Maja; George Jacob; Ziporen Lea; Shoenfeld Yehuda
    Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome
    1996
  62. Salobir-Pajnič B
    Koagulacija in fibrinoliza pri mladih ženskah, ki so prebolele trombembolijsko bolezen
    1995
  63. Ziporen L; Goldberg I; Arad M; Hojnik M; Ordi-Ros J; Afek A; Blank M; Sandbank Y; Vilardell-Tarres M; de Tores I
    Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves
    1996
  64. Rozman B; Božič B; Kveder T; Vizjak A; Ferluga D
    Does antiphospholipid syndrome without antiphospholipid antibodies exist?
    1994
  65. Božič Borut
    Podrobna specifičnost in pomen avtoprotiteles proti proteinom ribonukleoproteinskega delca Ro in fosfolipidom
    [The fine specificity and significance of autoantibodies against proteins of the ribonucleoprotein particle Ro and phospholipids]
    1994
  66. Božič B; Hojnik M; Kveder T; Rozman B; Jurčić V; Vizjak A; Ferluga D
    Antifosfolipidna protitelesa in antifosfolipidni sindrom
    [Antiphospholipid antibodies and antiphospholipid syndrome]
    1994
  67. Stegnar Mojca; Božic Borut; Peternel Polona; Kveder Tanja; Vene Nina; Rozman Blaž
    Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis
    1991
  68. Stegnar M; Salobir-Pajnič B; Božič B; Rozman B
    Relationship between lupus anticoagulants and antiphospholipid antibodies detected by enzyme-linked immunosorbent assay
    1992
  69. Salobir-Pajnič B
    Občutljivost nekaterih testov strjevanja krvi za antifosfolipidna protitelesa
    [The sensitivity of some blood coagulation tests for determining antiphospholipid antibodies]
    1991

   1 101



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics